Patents Assigned to Oxford University
-
Publication number: 20240383827Abstract: The invention relates to a process for producing a compound comprising an 18F-difluoromethyl group or a compound comprising an 18F-difluoromethylene group, which process comprises contacting a compound comprising a nucleophilic group with 18F-difluorocarbene. The invention also relates to a compound of Formula (I). Compounds comprising an 18F-difluoromethyl group or an 18F-difluoromethylene group are also the subject of the present invention.Type: ApplicationFiled: September 22, 2022Publication date: November 21, 2024Applicant: Oxford University innovation LimitedInventors: Veronique Emilie Bernardine Marie Gouverneur, Claudio Flavio Meyer, Jeroen Bart I. Sap
-
Patent number: 12144533Abstract: Apparatus and methods for electrosurgery are disclosed. In one arrangement, an electrosurgical element and a control system are provided. The electrosurgical element is electrically driven in a first electrical driving mode. The first electrical driving mode is such as to cause heating of human or animal tissue by the electrosurgical element. The heating contributes to modification or cutting of tissue by the electrosurgical element. The electrosurgical element is electrically driven in a second electrical driving mode. An electrical response of the electrosurgical element is measured during the electrical driving of the electrosurgical element in the second electrical driving mode.Type: GrantFiled: October 2, 2019Date of Patent: November 19, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Kamaljit Singh Chana, Parvinderpal Singh Sains, Vikram Sridhar, Richard T. Bryan
-
Patent number: 12122805Abstract: A method of detecting a protein by mass spectrometry comprises: providing a solution comprising a dendritic detergent and a protein; providing a mass spectrometer comprising a nanoelectrospray ionisation source, a mass analyser and a detector; vaporising the solution using the nanoelectrospray ionisation source; ionising the protein; resolving the ionised protein using the mass analyser; and detecting the resolved protein using the detector. A method of extracting a membrane protein from its native membrane comprises: providing a membrane protein in its native membrane; contacting the membrane protein with a dendritic detergent. Dendritic detergents for use in the methods are also provided.Type: GrantFiled: September 4, 2019Date of Patent: October 22, 2024Assignees: OXFORD UNIVERSITY INNOVATION LIMITED, FREIE UNIVERSITÄT BERLINInventors: Carol V. Robinson, Idlir Liko, Hsin-Yung Yen, Kevin Pagel, Rainer Haag, Svenja Christina Ehrmann, Leonhard Hagen Urner
-
Patent number: 12121885Abstract: A photocatalyst is described that is suitable for converting molecular nitrogen into ammonia. The photocatalyst comprises a layered base material comprising 1 to 100 layers, the layered base material being selected from the group consisting of molybdenum disulfide, tungsten disulfide, molybdenum telluride, tungsten telluride, molybdenum selenide and tungsten selenide, a layered base material comprising 1 to 100 layers, the layered base material being selected from the group consisting of molybdenum disulfide, tungsten disulfide, molybdenum telluride, tungsten telluride, molybdenum selenide and tungsten selenide, and 0.1-10.0% by weight, relative to the weight of the base material, of one or more Group VI, VII, VIII, IX or X transition metals. The photocatalyst can further comprise 0.1-50.0% by weight, relative to the weight of the base material, of one or more semiconductor materials having an average particle size of 0.5-50.0 nm.Type: GrantFiled: March 18, 2020Date of Patent: October 22, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Shik Chi Edman Tsang, Jianwei Zheng
-
Patent number: 12116633Abstract: A method of investigating the monotypia of a population of T-cells comprising detecting expression of the T cell receptor beta chain constant region TRBC1 and TRBC2, and/or the T cell receptor gamma chain constant region TRGC1 and TRGC, in a population of T-cells.Type: GrantFiled: October 2, 2015Date of Patent: October 15, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Graham Ogg, Elizabeth Soilleux
-
Patent number: 12114987Abstract: The present invention relates to a device for detecting a state of true perception loss of a human, the device including processing means operable to detect from information on electrical signals sensed adjacent to the scalp of the human the activity of oscillations present in the electrical signals as a marker for the state of true perception loss of the human.Type: GrantFiled: December 19, 2019Date of Patent: October 15, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Roisin Judith Ni Mhuircheartaigh, Irene Tracey, Katie Warnaby, Saad Jbabdi, Richard Rogers
-
Patent number: 12109060Abstract: Systems and methods are provided for assessing microvascular dysfunction of a patient. A series of images is acquired of a region of interest within the body of the patient. An imaging-derived index of microcirculatory resistance is determined from the series of images. A clinical parameter representing microvascular dysfunction is assigned to the patient via a predictive model according to at least the imaging-derived index of microcirculatory resistance.Type: GrantFiled: October 12, 2020Date of Patent: October 8, 2024Assignees: MEDSTAR HEALTH, INC., OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUSTInventors: Hector Manuel Garcia Garcia, Giovanni Luigi De Maria, Adrian P. Banning
-
Patent number: 12111456Abstract: The application discloses a method and apparatus for imaging a sample by interferometric scattering microscopy, the method comprising illuminating a sample with at least one coherent light source, the sample being held at a sample location comprising an interface having a refractive index change, illuminating the sample with illuminating radiation to generate a backpropagating signal from the sample comprising light reflected at the interface and light scattered by the sample, splitting the backpropagating signal into first and second signals, modifying the second signal using a modifying element such that the second signal differs from the first signal, directing the first and second signals onto first and second detectors to generate, respectively, first and second images and comparing, by a processor, the first and second images to determine one or more characteristics of the sample.Type: GrantFiled: October 9, 2020Date of Patent: October 8, 2024Assignees: Refeyn Ltd, Oxford University Innovation LimitedInventors: Matthias Karl Franz Langhorst, Daniel Richard Cole, David John Lehar Graham, Philipp Kukura, Lee Priest
-
Patent number: 12102463Abstract: A method for characterising an epicardial region using medical imaging data of a subject. The method comprises calculating the value of an epicardial radiomic signature of the epicardial region using the medical imaging data. Also disclosed is a method for deriving an epicardial radiomic signature indicative of cardiac health. The method comprises using a radiomic dataset to construct an epicardial radiomic signature. Also disclosed are systems for performing the aforementioned methods.Type: GrantFiled: October 29, 2019Date of Patent: October 1, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Charalambos Antoniades, Alexios Antonopoulos, Henry West
-
Publication number: 20240316050Abstract: The present invention relates to the use of a reduced folate, such as 5-MTHF (5-methyltetrahydrofolate), optionally in combination with tetrahydrobiopterin (BH4) or precursors thereof, for preventing or treating disorders associated with a BH4 deficiency, or low BH4 bioavailability. Such disorders primarily include diseases which have vascular endothelial pathology, or effects on amino acid metabolism or neurotransmission, especially pregnancy related disorders such as pre-eclampsia.Type: ApplicationFiled: December 21, 2021Publication date: September 26, 2024Applicant: OXFORD UNIVERSITY INNOVATION LIMITEDInventor: Keith CHANNON
-
Patent number: 12098954Abstract: A hyperspectral imaging device (100) is provided comprising an input (102) for receiving a light field from a scene (106), an encoder (108), at least one dispersive element (110, 112), at least one array detector (114, 110) and a processor (118). The encoder (108) is arranged to receive at least a portion of the light field from the input (102) and transform it to provide a first and second encoded light (120, 122) field having different spatial patterns. At least one dispersive element (110, 112) is arranged to apply spectral shear to the first and second encoded light fields (120, 122) respectively to provide first and second sheared light fields (124, 126). At least one array detector (114, 116) is arranged to detect the first and second sheared light fields (124, 126). The processor (118) is arranged to process an output from the at least one array detector (114, 116) to determine a datacube (128) corresponding to a hyperspectral image of the scene.Type: GrantFiled: September 4, 2020Date of Patent: September 24, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Robin Wang, Peter Norreys
-
Publication number: 20240301443Abstract: The present invention provides recombinant adenoviral vectors, immunogenic compositions thereof and their uses in medicine. In particular, the present invention provides an adenoviral vector comprising the genome of an adenovirus other than AdHu5 and AdY25, wherein the genome of the adenovirus has been modified such that the vector lacks the native E4 locus of the adenovirus and comprises heterologous E4Orf1, E4Orf2 and E4Orf3 coding regions from AdY25.Type: ApplicationFiled: April 2, 2024Publication date: September 12, 2024Applicant: Oxford University Innovation LimitedInventors: Sarah C. Gilbert, Adrian VS Hill, Matthew G. Cottingham, Matthew Dicks, Susan J. Morris, Alexander Douglas
-
Publication number: 20240299563Abstract: Disclosed are conjugates of an oligonucleotide and a peptide covalently bonded or linked via a linker to the oligonucleotide, the peptide including at least one cationic domain comprising at least 4 amino acid residues and at least one hydrophobic domain comprising at least 3 amino acid residues, provided that the peptide includes a total of 7 to 40 amino acid residues and does not include any artificial amino acid residues; and the oligonucleotide including a total of 12 to 40 contiguous nucleobases, where at least 12 contiguous nucleobases are complementary to a target sequence in a human dystrophin gene.Type: ApplicationFiled: February 11, 2022Publication date: September 12, 2024Applicants: Oxford University Innovation Limited, United Kingdom Research and InnovationInventors: Matthew WOOD, Raquel MANZANO, Caroline GODFREY, Graham MCCLOREY, Richard RAZ, Michael GAIT, Andrey ARZUMANOV, Liz O'DONOVAN, Gareth HAZELL, Ashling HOLLAND, Miguel VARELA, Subhashis BANERJEE
-
Publication number: 20240296658Abstract: This disclosure teaches multi-classification of endoscopic imaging using a segmentation neural network. The network is trained on imaging data using a novel loss function with components of both focal and boundary loss. During a lithotripsy procedure, images are received by a deployed endoscopic probe. Based on the received imaging data and inference data from its prior learning, the segmentation neural network identifies renal calculi and surgical instruments within the imaging data. The imaging data is modified and displayed to assist the lithotripsy procedure.Type: ApplicationFiled: February 27, 2024Publication date: September 5, 2024Applicants: The Chancellor, Masters and Scholars of the University of Oxford, Oxford University Innovation Limited, Boston Scientific Scimed Inc.Inventors: Soumya Gupta, Sharib Ali, Jens Rittscher, Benjamin Turney, Niraj Prasad Rauniyar, Aditi Ray, Longquan Chen
-
Patent number: 12071390Abstract: A process for preparing a fluorinating reagent from a calcium-containing compound is disclosed. The process bypasses the requirement to form hydrofluoric acid. The fluorinating reagent can be used to prepare high-value fluorochemicals.Type: GrantFiled: May 24, 2023Date of Patent: August 27, 2024Assignee: Oxford University Innovation LimitedInventors: Veronique Gouverneur, Gabriele Pupo, Duncan Browne, Jamie Leitch
-
Patent number: 12073966Abstract: The invention relates to a process for moving a droplet from a first location to a second location, which droplet comprises a magnetic material disposed in an aqueous medium. The invention also relates to a droplet assembly comprising a droplet, which droplet comprises a magnetic material disposed in an aqueous medium. Various uses of the droplet assembly are also described.Type: GrantFiled: February 2, 2021Date of Patent: August 27, 2024Assignee: Oxford University Innovation LimitedInventors: John Hagan Pryce Bayley, Kunwar Tanuj Sapra, Tobias Wauer, Holger Gerlach, Shiksha Mantri, Jamie Hill
-
Patent number: 12072287Abstract: A scattering microscopy arrangement uses a microscope to image an object comprising a surface. A light source emits illuminating light and a light detector detects light elastically scattered from the object. An electric potential is applied to the surface that affects the electrochemical properties of the object while imaging. The electric potential provides a contrast mechanism that improves the imaging and allows for characterisation of the object and/or the surrounding environment.Type: GrantFiled: March 12, 2020Date of Patent: August 27, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Philipp Kukura, Sanli Faez
-
Publication number: 20240280496Abstract: A reagent reaction determination method and device applied to a test tube, a computer-readable storage medium and a test tube, wherein, the reagent reaction determination method comprises: outputting a brightness control signal to the light-incident component to control the light-incident component to emit the RGB light, and to adjust the brightness control signal according to a preset step length, so as to adjust the brightness of the RGB light; detecting brightness variations of the light derived by the light-emergent component to generate an electrical signal detection value; perform an interpolation calculation on the present brightness control signal to obtain an estimated value of the brightness control signal when the electrical signal detection value is less than a preset threshold, and determining a reaction result in the reagent reaction chamber according to the estimated value of the brightness control signal. The reagent reaction determination device can greatly improve the user experience.Type: ApplicationFiled: March 6, 2024Publication date: August 22, 2024Applicant: OXFORD UNIVERSITY (SUZHOU) SCIENCE & TECHNOLOGY CO., LTD.Inventors: Danny Sheng Wu YEUNG, Wu-Po MA, Shu WU, Yung Ho Peter WONG, Senthil Kumar SUNDARAM, Dingge YING, Hoi Ting Janette CHU, Kevin Clark TAN, Chia-Chen HSU, Allysson Ferreira DOMINGUES, Alex MAUND, William CHUNG-HOW
-
Publication number: 20240277209Abstract: This disclosure teaches determining a renal calculus size based on calibration data generated from an endoscopic imager. During a lithotripsy procedure, images are received by a deployed endoscopic probe. Based on the received imaging data, the generated calibration data, and known properties of the endoscopic probe, one or more renal calculi in the images are identified and sized. The determined size values are displayed with the images of the renal calculi.Type: ApplicationFiled: February 19, 2024Publication date: August 22, 2024Applicants: The Chancellor, Masters and Scholars of the University of Oxford, Oxford University Innovation Limited, Boston Scientific Scimed Inc.Inventors: Soumya Gupta, Sharib Ali, Jens Rittscher, Benjamin Turney, Niraj Prasad Rauniyar, Aditi Ray, Longquan Chen
-
Patent number: 12064477Abstract: The invention relates to a nucleic acid encoding a polypeptide comprising a plurality of conserved peptide sequences, or variants thereof, wherein the conserved sequences are conserved across one or more HPV genotypes 16, 18, 31, 52, 53, and 58; and wherein the polypeptide comprises a conserved peptide sequence of each of the HPV proteins E1, E2, E4, E5, E6, and E7; and associated vaccines, viral vectors, treatment and prophylaxis.Type: GrantFiled: November 22, 2021Date of Patent: August 20, 2024Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: Lucy Dorrell, Joshua Blight, Arturo Reyes-Sandoval